FDA approves Gilead’s remdesivir, first drug for treating COVID-19 October 22, 2020 The U.S. Food and Drug Administration on Thursday approved Gilead Sciences’ antiviral drug remdesivir as a treatment for COVID-19 patients requiring hospitalization. Full Story
